Courtney C. Enloe - 24 Apr 2025 Form 4 Insider Report for BIO-RAD LABORATORIES, INC. (BIO)

Role: EVP, General Counsel & Sec
Signature: /s/ Courtney C. Enloe
Issuer symbol: BIO
Transactions as of: 24 Apr 2025
Net transactions value: -$16,733
Form type: 4
Filing time: 25 Apr 2025, 18:06:43 UTC
Previous filing: 05 Mar 2025
Next filing: 09 Sep 2025
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	BIO BIOB	Bio-Rad A Common Stock	Options Exercise	$0	+186	+1790%	$0.000000	196	24 Apr 2025	Direct	F1, F2
transaction	BIO BIOB	Bio-Rad A Common Stock	Tax liability	$16,733	-67	-34%	$249.74	129	24 Apr 2025	Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	BIO BIOB	Restricted Stock Units	Options Exercise	$0	-186	-25%	$0.000000	558	24 Apr 2025	Bio-Rad A Common Stock	186	$0.000000	Direct	F3, F4

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Shares of Class A common stock acquired on the vesting of restricted stock units.
F2	Includes 5.5730 shares acquired under the Bio-Rad Employee Stock Purchase Plan on 03/31/2025.
F3	Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock.
F4	On April 24, 2024, the reporting person was granted 744 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date.